Citations

Showing 10 of 108081 citations.

Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
Duong, Vu H. , Ruppert, Amy S. , Borate, Uma , Stein, Eytan M. , Baer, Maria R. , Kovacsovics, Tibor , Blum, William , Arellano, Martha , Schiller, Gary J. , Olin, Rebecca L. , Foran, James M. , Litzow, Mark R. , Patel, Prapti A. , Redner, Robert L. , Al‐Mansour, Zeina , Swords, Ronan , Collins, Robert H. , Vergilio, Jo‐Anne, Heerema, Nyla A. , Rosenberg, Leonard, Yocum, Ashley O. , Marcus, Sonja, Druggan, Franchesca , Stefanos, Mona , Gana, Theophilus J. , Burd, Amy , Byrd, John C. , Levine, Ross L. , Boyiadzis, Michael , Byrd, John C. , Blum, William , Arellano, Martha L , Foran, James M , Lin, Tara L , Gana, Theophilus J , Duong, Vu H , Byrd, John C , Mims, Alice S , Stock, Wendy , Lin, Tara L. , Foster, Matthew C , Cogle, Christopher Ramin , Chen, Timothy Frank , Shoben, Abigail B. , Druker, Brian J

Mayo Clinic

Cancer | April 20, 2023 | Volume: 129 | Issue: 15 | Pages: 2308-2320

10.1002/cncr.34780 | PMID 37078412 Get It

AbstractBackgroundPatients with acute myeloid leukemia (AML) who have tumor protein p53 (TP53) mutations or a complex karyotype have a poor prognosis, and hypomethylating agents are often used. The authors evaluated the efficacy of entospletinib, an oral inhibitor of spleen tyrosine kinase, combined with decitabine in this patient population.MethodsThis was a multicenter, open‐label, phase 2 substudy of the Beat AML Master Trial (ClinicalTrials.gov identifier NCT03013998) using a Simon two‐stage design. Eligible patients aged 60 years or older who had newly diagnosed AML with mutations in TP53 with or without a complex karyotype (cohort A; n = 45) or had a complex karyotype without TP53 mutation (cohort B; n = 13) received entospletinib 400 mg twice daily with decitabine 20 mg/m2 on days 1–10 every 28 days for up to three induction cycles, followed by up to 11 consolidation cycles, in which decitabine was reduced to days 1–5. Entospletinib maintenance was given for up to 2 years. The primary end point was complete remission (CR) and CR with hematologic improvement by up to six cycles of therapy.ResultsThe composite CR rates for cohorts A and B were 13.3% (95% confidence interval, 5.1%–26.8%) and 30.8% (95% confidence interval, 9.1%–61.4%), respectively. The median duration of response was 7.6 and 8.2 months, respectively, and the median overall survival was 6.5 and 11.5 months, respectively. The study was stopped because the futility boundary was crossed in both cohorts.ConclusionsThe combination of entospletinib and decitabine demonstrated activity and was acceptably tolerated in this patient population; however, the CR rates were low, and overall survival was short. Novel treatment strategies for older patients with TP53 mutations and complex karyotype remain an urgent need.
An overview of the resilience world: Proceedings of the American Geriatrics Society and National Institute on Aging State of Resilience Science Conference
Bandeen‐Roche, Karen , Bergeman, C. S. , Bennett, David A. , Davis, Daniel , Kind, Amy , Whitson, Heather E. , Bennett, David A. , LeBrasseur, Nathan, Abadir, Peter , LeBrasseur, Nathan K. , Stern, Yaakov , Varadhan, Ravi

Mayo Clinic

Journal of the American Geriatrics Society | April 20, 2023 | Volume: 71 | Issue: 8 | Pages: 2381-2392

10.1111/jgs.18388 | PMID 37079440 Get It

Abstract Resilience, which relates to one's ability to respond to stressors, typically declines with age and the development of comorbid conditions in older organisms. Although progress has been made to improve our understanding of resilience in older adults, disciplines have employed different frameworks and definitions to study various aspects of older adults' response to acute or chronic stressors. “Overview of the Resilience World: State of the Science,” a bench‐to‐bedside conference on October 12–13, 2022, was sponsored by the American Geriatrics Society and National Institute on Aging. This conference, summarized in this report, explored commonalities and differences among the frameworks of resilience most commonly used in aging research in the three domains of resilience: physical, cognitive, and psychosocial. These three main domains are intertwined, and stressors in one domain can lead to effects in other domains. The themes of the conference sessions included underlying contributors to resilience, the dynamic nature of resilience throughout the life span, and the role of resilience in health equity. Although participants did not agree on a single definition of “resilience(s),” they identified common core elements of a definition that can be applied to all domains and noted unique features that are domain specific. The presentations and discussions led to recommendations for new longitudinal studies of the impact of exposures to stressors on resilience in older adults, the use of new and existing cohort study data, natural experiments (including the COVID‐19 pandemic), and preclinical models for resilience research, as well as translational research to bring findings on resilience to patient care.
Commentary: Daily Pain Prediction Using Smartphone Speech Recordings of Patients With Spine Disease
Bydon, Mohamad , Johnson, Sarah E. , Katsos, Konstantinos, Katsos, Konstantinos D.

Mayo Clinic

Neurosurgery | April 20, 2023 | Volume: 93 | Issue: 3 | Pages: e61-e62

10.1227/neu.0000000000002503 | PMID 37078725 Get It

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn’s disease and leads to impaired CFB cleavage and phagocytosis
Akhlaghpour, Marzieh, Haritunians, Talin , More, Shyam K., Thomas, Lisa , Stamps, Dalton T., Dube, Shishir, Li, Dalin , Yang, Shaohong, Landers, Carol J., Hamade, Hussein , Murali, Ramachandran , Potdar, Alka A. , Wolf, Andrea J. , Botwin, Gregory J., Khrom, Michelle , Faubion, William A. , Jabrì, Bana , Lira, Sérgio A. , Newberry, Rodney D. , Sandler, Robert S. , Sartor, R. Balfour , Xavier, Ramnik J. , Lazarev, Mark , Rioux, John D. , Silverberg, Mark S. , Zaghiyan, Karen , Fleshner, Phillip , Melmed, Gil , Vasiliauskas, Eric A., Ha, Christina , Rabizadeh, Shervin , Syal, Gaurav , Bonthala, Nirupama , Ziring, David , Targan, Stephan R. , Long, Millie D. , Michelsen, Kathrin S. , Nöthen, Markus M. , Ellinghaus, David , D’Amato, Mauro , Halfvarson, Jonas , Lee, James , Limbergen, Johan Van , Mowat, Craig , Hamade, Hussein , Ananthakrishnan, A N , Lira, Sergio A , Cho, Judy H , Michelsen, Kathrin S , Haritunians, Talin , Ellinghaus, David , D'Amato, Mauro , Nöthen, Markus M , Sandler, Robert S , Melmed, Gil Y , Halfvarson, Jonas , Newberry, Rodney D , Rioux, John D , Mengesha, Emebet , Ananthakrishnan, Ashwin N. , Jabrì, Bana , Brant, Steven R , Duerr, Richard H , Schumm, L. Philip , McGovern, Dermot , Lee, James C.

Mayo Clinic

Gut | April 20, 2023 | Volume: 72 | Issue: 11 | Pages: 2068-2080

10.1136/gutjnl-2023-329689 | PMID 37080587 Get It

Objective Perianal Crohn’s disease (pCD) occurs in up to 40% of patients with CD and is associated with poor quality of life, limited treatment responses and poorly understood aetiology. We performed a genetic association study comparing CD subjects with and without perianal disease and subsequently performed functional follow-up studies for a pCD associated SNP in Complement Factor B ( CFB ). Design Immunochip-based meta-analysis on 4056 pCD and 11 088 patients with CD from three independent cohorts was performed. Serological and clinical variables were analysed by regression analyses. Risk allele of rs4151651 was introduced into human CFB plasmid by site-directed mutagenesis. Binding of recombinant G252 or S252 CFB to C3b and its cleavage was determined in cell-free assays. Macrophage phagocytosis in presence of recombinant CFB or serum from CFB risk, or protective CD or healthy subjects was assessed by flow cytometry. Results Perianal complications were associated with colonic involvement, OmpC and ASCA serology, and serology quartile sum score. We identified a genetic association for pCD (rs4151651), a non-synonymous SNP (G252S) in CFB , in all three cohorts. Recombinant S252 CFB had reduced binding to C3b, its cleavage was impaired, and complement-driven phagocytosis and cytokine secretion were reduced compared with G252 CFB. Serine 252 generates a de novo glycosylation site in CFB. Serum from homozygous risk patients displayed significantly decreased macrophage phagocytosis compared with non-risk serum. Conclusion pCD-associated rs4151651 in CFB is a loss-of-function mutation that impairs its cleavage, activation of alternative complement pathway, and pathogen phagocytosis thus implicating the alternative complement pathway and CFB in pCD aetiology.
COVID-19: Factors Associated with the Psychological Distress, Fear and Resilient Coping Strategies among Community Members in Saudi Arabia
Alharbi, Talal Ali F. , AlQurashi, Alaa , Mahmud, Ilias , Alharbi, Rayan Jafnan , Islam, Sheikh Mohammed Shariful , Almustanyir, Sami , Maklad, Ahmed Essam , AlSarraj, Ahmad, Mughaiss, Lujain Nedhal, Al‐Tawfiq, Jaffar A. , Ahmed, Ahmed Ali , Barry, Mazin , Alabdan, Lulwah Ibrahim, Alif, Sheikh Mohammad , Sultana, Farhana , Salehin, Masudus , Banik, Biswajit , Rahman, Muhammad Aziz , Alqurashi, Alaa Ashraf Bagader , Alif, Sheikh M , Salehin, Masudus , Rahman, Muhammad Aziz , Islam, Sheikh Mohammed Shariful , Ghozy, Sherief , Cross, Wendy M

Mayo Clinic

Healthcare | April 20, 2023 | Volume: 11 | Issue: 8 | Pages: 1184

10.3390/healthcare11081184 | PMID 37108018 Get It

(1) Background: COVID-19 caused the worst international public health crisis, accompanied by major global economic downturns and mass-scale job losses, which impacted the psychosocial wellbeing of the worldwide population, including Saudi Arabia. Evidence of the high-risk groups impacted by the pandemic has been non-existent in Saudi Arabia. Therefore, this study examined factors associated with psychosocial distress, fear of COVID-19 and coping strategies among the general population in Saudi Arabia. (2) Methods: A cross-sectional study was conducted in healthcare and community settings in the Saudi Arabia using an anonymous online questionnaire. The Kessler Psychological Distress Scale (K-10), Fear of COVID-19 Scale (FCV-19S) and Brief Resilient Coping Scale (BRCS) were used to assess psychological distress, fear and coping strategies, respectively. Multivariate logistic regressions were used, and an Adjusted Odds Ratio (AOR) with 95% Confidence Intervals (CIs) was reported. (3) Results: Among 803 participants, 70% (n = 556) were females, and the median age was 27 years; 35% (n = 278) were frontline or essential service workers; and 24% (n = 195) reported comorbid conditions including mental health illness. Of the respondents, 175 (21.8%) and 207 (25.8%) reported high and very high psychological distress, respectively. Factors associated with moderate to high levels of psychological distress were: youth, females, non-Saudi nationals, those experiencing a change in employment or a negative financial impact, having comorbidities, and current smoking. A high level of fear was reported by 89 participants (11.1%), and this was associated with being ex-smokers (3.72, 1.14–12.14, 0.029) and changes in employment (3.42, 1.91–6.11, 0.000). A high resilience was reported by 115 participants (14.3%), and 333 participants (41.5%) had medium resilience. Financial impact and contact with known/suspected cases (1.63, 1.12–2.38, 0.011) were associated with low, medium, to high resilient coping. (4) Conclusions: People in Saudi Arabia were at a higher risk of psychosocial distress along with medium-high resilience during the COVID-19 pandemic, warranting urgent attention from healthcare providers and policymakers to provide specific mental health support strategies for their current wellbeing and to avoid a post-pandemic mental health crisis.
Physical functioning following spinal cord stimulation: a systematic review and meta-analysis
ElSaban, Mariam , Kleppel, Donald J , Kubrova, Eva , Alvarez, Gabriel A Martinez , Hussain, Nasir , D’Souza, Ryan S. , Martinez Alvarez, Gabriel A , D'Souza, Ryan S

Mayo Clinic

Regional Anesthesia & Pain Medicine | April 20, 2023 | Volume: 48 | Issue: 6 | Pages: 302-311

10.1136/rapm-2022-104295 | PMID 37080578 Get It

Background Spinal cord stimulation (SCS) has emerged as an important treatment for chronic pain disorders. While there is evidence supporting improvement in pain intensity with SCS therapy, efforts to synthesize the evidence on physical functioning are lacking. Objective The primary objective of this meta-analysis was to assess long-term physical function following 12 months of SCS for chronic back pain. Evidence review PubMed, EMBASE, Scopus, and CENTRAL databases were searched for original peer-reviewed publications investigating physical function following SCS. The primary outcome was physical function at 12 months following SCS therapy for chronic back pain compared with baseline. A random effects model with an inverse variable method was used. The Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) framework was used to determine the certainty of evidence. Findings A total of 518 studies were screened, of which 36 were included. Twenty-two studies were pooled in the meta-analysis. There was a significant reduction in Oswestry Disability Index (ODI) scores at all time frames up to 24 months following implantation. Pooled results revealed significant improvement in ODI scores at 12 months with a mean difference of −17.00% (95% CI −23.07 to −10.94, p<0.001). There was a very low certainty of evidence in this finding as per the GRADE framework. There was no significant difference in subgroup analyses based on study design (randomised controlled trials (RCTs) vs non-RCTs), study funding, or stimulation type. Conclusion This meta-analysis highlights significant improvements in physical function after SCS therapy. However, this finding was limited by a very low GRADE certainty of evidence and high heterogeneity.
The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on Brassetti et al. Combined Reporting of Surgical Quality and Can
May, Matthias , Lebentrau, Steffen , Protzel, Chris, Chahoud, Jad , Pettaway, Curtis A. , Pagliaro, Lance C. , Watkin, Nick , Spiess, Philippe E. , Spiess, Philippe E , Ayres, Benjamin Edward , Albersen, Maarten , Brouwer, Oscar R. , Necchi, Andrea , Hakenberg, Oliver Walter

Mayo Clinic

Current Oncology | April 20, 2023 | Volume: 30 | Issue: 4 | Pages: 4269-4274

10.3390/curroncol30040325 | PMID 37185438 Get It

We read with great interest the manuscript by Brassetti et al. recently published in your journal and hope it will encourage discussion and debate around the optimization of the surgical management of patients with penile cancer (PECa) [...]
Survey of Nutrition Education Among Medical Students
Duggan, Michael P. , Kodali, Anahita , Panton, Zach A, Smith, Shannon M. , Riew, Grant J. , Donaghue, Jack F. , Leya, Gregory , Panton, Zachary A , Briggs, Logan

Mayo Clinic

Journal of Wellness | April 20, 2023 | Volume: 4 | Issue: 2 | Pages: No page available

10.55504/2578-9333.1167 Get It

Introduction: The current literature regarding both specific interventions and the current level of nutrition education in the United States is scarce. The purpose of this paper is to provide medical student perspectives on both the degree and necessity of nutrition education during medical school. Methods: Medicine in Motion (MM) is a non-profit student-run organization founded in 2018 that aims to address burnout in medicine through physical activity, community service, and philanthropy. MM issued a survey to nine of its chapters in January 2021 to assess a range of topics including burnout, physical activity, and nutrition education. Results: Of 5500 invited students, 1182 (21.5%) responded. An average of 1.2 hours of formal nutrition education per year was reported across all participants. Students who received any degree of nutritional education reported 2.9 hours per year. Most students (57.6%) had not participated in a medical school course that provided formal education in nutrition. Of those that did participate in a nutrition course (42.4%), the course was required for 84.7% of students and the majority (80.1%) received 0-10 hours of nutrition education. Most respondents (88.7%) reported that requiring formal nutrition education should be a graduation requirement and a similar number of students (89.3%) believe medical students should receive formal training on nutrition counseling for patients. The majority (93.3%) of students either somewhat or strongly agreed that understanding the effects of nutrition/eating decisions on the human body is critical to maximizing patient care. Conclusion: Based on prior studies, physicians feel underprepared to provide nutrition counseling to their patients despite the large role poor diet plays in the burden of disease. Most medical students in this cohort believe that understanding nutrition is vital to maximize patient care. Funding and curricular changes should be allocated towards expanding the nutrition curriculum across U.S. medical schools.
Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study
Frazee, Erin N. , Chitre, Pooja N., Shepel, Kathryn, Aziz, Mohd. Hafiz Abdul, Ausman, Sara , Moreland-Head, Lindsay N, Jannetto, Paul J. , Mara, Kristin C. , Boehmer, Kasey R. , Shepel, Kathryn K, Ausman, Sara E., Mara, Kristin C , Chitre, Pooja , Pine, Kathleen H. , Rule, Andrew D. , Al‐Shaer, Mohammad H. , Abdul-Aziz, Mohd Hafiz , Roberts, Jason A , Scheetz, Marc H. , Ausman, Sara E , Rivera, Christina G.

Mayo Clinic

Therapeutic Drug Monitoring | April 20, 2023 | Volume: 45 | Issue: 4 | Pages: 508-518

10.1097/ftd.0000000000001059 | PMID 37076424 Get It

Background: Beta-lactam therapeutic drug monitoring (BL TDM; drug level testing) can facilitate improved outcomes in critically ill patients. However, only 10%–20% of hospitals have implemented BL TDM. This study aimed to characterize provider perceptions and key considerations for successfully implementing BL TDM. Methods: This was a sequential mixed-methods study from 2020 to 2021 of diverse stakeholders at 3 academic medical centers with varying degrees of BL TDM implementation (not implemented, partially implemented, and fully implemented). Stakeholders were surveyed, and a proportion of participants completed semistructured interviews. Themes were identified, and findings were contextualized with implementation science frameworks. Results: Most of the 138 survey respondents perceived that BL TDM was relevant to their practice and improved medication effectiveness and safety. Integrated with interview data from 30 individuals, 2 implementation themes were identified: individual internalization and organizational features. Individuals needed to internalize, make sense of, and agree to BL TDM implementation, which was positively influenced by repeated exposure to evidence and expertise. The process of internalization appeared more complex with BL TDM than with other antibiotics (ie, vancomycin). Organizational considerations relevant to BL TDM implementation (eg, infrastructure, personnel) were similar to those identified in other TDM settings. Conclusions: Broad enthusiasm for BL TDM among participants was found. Prior literature suggested that assay availability was the primary barrier to implementation; however, the data revealed many more individual and organizational attributes, which impacted the BL TDM implementation. Internalization should particularly be focused on to improve the adoption of this evidence-based practice.
Artificial Intelligence: Singularity Approaches
TerKonda, Sarvam P. , TerKonda, Anurag A., Sacks, Justin M. , Kinney, Brian M. , Gurtner, Geoff C., Nachbar, James M., Reddy, Sashank , Jeffers, Lynn L., Jeffers, Lynn

Mayo Clinic

Plastic & Reconstructive Surgery | April 19, 2023 | Volume: 153 | Issue: 1 | Pages: 204e-217e

10.1097/prs.0000000000010572 | PMID 37075274 Get It

Summary: Artificial intelligence (AI) has been a disruptive technology within health care, from the development of simple care algorithms to complex deep-learning models. AI has the potential to reduce the burden of administrative tasks, advance clinical decision-making, and improve patient outcomes. Unlocking the full potential of AI requires the analysis of vast quantities of clinical information. Although AI holds tremendous promise, widespread adoption within plastic surgery remains limited. Understanding the basics is essential for plastic surgeons to evaluate the potential uses of AI. This review provides an introduction of AI, including the history of AI, key concepts, applications of AI in plastic surgery, and future implications.